Loading clinical trials...

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01687270

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

This is an open-label, single-arm study of sofosbuvir (GS-7977) and ribavirin (RBV) in adults who have had a liver transplant which has become re-infected with hepatitis C. The treatment period is 24 ...

Lead sponsor: Gilead Sciences•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 2/3

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

NCT03386305 · Post Liver Transplant

COMPLETEDNA

Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation

NCT01339078 · Biliary Strictures Post Liver Transplantation

TERMINATEDNA

Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity

NCT00878592 · Post Liver Transplantation Weight Gain, Post Liver Transplantation Obesity, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 19, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment40

Start dateNov 2012

Last updatedDec 19, 2014

Condition

Recurrent Chronic Hepatitis C Virus Post Liver Transplant

Locations shown

San Francisco, California

Indianapolis, Indiana

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions